First Citizens Bank & Trust’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-5,988
Closed -$314K 417
2020
Q3
$314K Buy
+5,988
New +$248K 0.02% 246

First Citizens Bank & Trust's MNTA Position: Q4 2020 in Review

First Citizens Bank & Trust sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 5,988 shares — an estimated $314K sold.

First Citizens Bank & Trust first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $314K in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • First Citizens Bank & Trust reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • First Citizens Bank & Trust sold 5,988 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $314K.
  • First Citizens Bank & Trust first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • First Citizens Bank & Trust's Momenta Pharmaceuticals, Inc. position peaked at $314K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on First Citizens Bank & Trust's 13F filing for Q4 2020, filed 13 Jan 2021.